Publications by authors named "Matthew G Fury"

51Publications

PD-1 Blockade with Cemiplimab in Advanced Cutaneous Squamous-Cell Carcinoma.

N Engl J Med 2018 07 4;379(4):341-351. Epub 2018 Jun 4.

From the Departments of Dermatology and Head and Neck Surgery, University of Texas MD Anderson Cancer Center, Houston (M.R.M.), and South Texas Accelerated Research Therapeutics (START), San Antonio (K.P.P.) - both in Texas; the Department of Medical Oncology, Peter MacCallum Cancer Centre and University of Melbourne, Melbourne, VIC (D.R., A.A.T.), the Department of Medical Oncology, Royal North Shore Hospital, St. Leonards, VIC (A.G.), the Department of Medical Oncology, Sir Charles Gairdner Hospital, Perth, WA (A.M.L.), and Royal Brisbane and Women's Hospital and University of Queensland, Brisbane (B.G.M.H.) - all in Australia; the Department of Dermatology, Brigham and Women's Hospital (C.D.S.), the Department of Dermatology, Harvard Medical School (C.D.S.), and the Department of Medical Oncology, Dana-Farber Cancer Institute (G.R.) - all in Boston; Schleswig-Holstein University Hospital, Kiel (A.H.), and University Hospital Essen, Essen and German Cancer Consortium, Essen (D.S.) - both in Germany; University of Colorado Denver, School of Medicine, Aurora (K.D.L.); the Departments of Head and Neck-Endocrine Oncology (C.H.C.) and Cutaneous Oncology (N.I.K.), H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL; the Division of Medical Oncology, Department of Medicine, Washington University School of Medicine, St. Louis (L.H.-A.); the Department of Dermatology, Stanford University School of Medicine, Redwood City (A.L.S.C.), and the Division of Dermatology, City of Hope, Duarte (B.M.) - both in California; the Department of Medicine, Head and Neck Medical Oncology, Memorial Sloan Kettering Cancer Center, New York (L.A.D.), and Regeneron Pharmaceuticals, Tarrytown (F.S., M.M., K.M., G.D.Y., I.L., M.G.F.) - both in New York; Regeneron Pharmaceuticals, Basking Ridge, NJ (B.G., S.L., J.L., J.B., E.S.); University of Arizona Cancer Center, Tucson (H.M.B.), and Banner MD Anderson Cancer (J.H.) and the Department of Medical Oncology, Banner MD Anderson Cancer Center (J.N.), Gilbert - all in Arizona; Medical Oncology Department, Vall D'Hebron University Hospital (I.B.), and Institut Català D'Oncologia, Oncobell Program (IDIBELL), L'Hospitalet de Llobregat (M.G.-M.), Barcelona, and START Madrid-FJD, Hospital Fundación Jiménez Díaz, Madrid (V.M.) - all in Spain; Sarah Cannon Research Institute, Nashville (M.L.J.); and the Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University, Atlanta (T.K.O.).

View Article

Download full-text PDF

Source
http://www.nejm.org/doi/10.1056/NEJMoa1805131
Publisher Site
http://dx.doi.org/10.1056/NEJMoa1805131DOI Listing
July 2018

Responses of metastatic basal cell and cutaneous squamous cell carcinomas to anti-PD1 monoclonal antibody REGN2810.

J Immunother Cancer 2016 15;4:70. Epub 2016 Nov 15.

Oncology Clinical Sciences, Regeneron Pharmaceuticals, 777 Old Saw Mill River Road, Tarrytown, NY 10591-6707 USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s40425-016-0176-3DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5109769PMC
February 2018

Reply to B. O'Sullivan et Al.

J Clin Oncol 2015 May 30;33(15):1710. Epub 2015 Mar 30.

Memorial Sloan Kettering Cancer Center, Weill Cornell Medical College, New York, NY.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2014.60.3563DOI Listing
May 2015

New chapter in our understanding of human papillomavirus-related head and neck cancer.

J Clin Oncol 2014 Oct 15;32(30):3349-52. Epub 2014 Sep 15.

Memorial Sloan Kettering Cancer Center, Weill Cornell Medical College, New York, NY.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2014.56.5754DOI Listing
October 2014

A phase 1 study of everolimus + weekly cisplatin + intensity modulated radiation therapy in head-and-neck cancer.

Int J Radiat Oncol Biol Phys 2013 Nov;87(3):479-86

Department of Medicine, Head and Neck Oncology Service, Memorial Sloan-Kettering Cancer Center, New York, New York; Department of Medicine, Weill Cornell Medical College, New York, New York.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijrobp.2013.06.2043DOI Listing
November 2013

Risk of hemoptysis in patients with resected squamous cell and other high-risk lung cancers treated with adjuvant bevacizumab.

Cancer Chemother Pharmacol 2013 Aug 28;72(2):453-61. Epub 2013 Jun 28.

Thoracic Oncology Service, Division of Solid Tumor Oncology, Department of Medicine, Memorial Sloan-Kettering Cancer Center, Weill Cornell Medical School, 300 East 66th Street, New York, NY 10065, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00280-013-2219-5DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4653739PMC
August 2013

Molecular-targeted therapies in head and neck cancer.

Semin Radiat Oncol 2012 Jul;22(3):207-13

Department of Radiation Oncology, Memorial Sloan-Kettering Cancer Center, New York, NY 10065, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.semradonc.2012.03.005DOI Listing
July 2012

A phase I study of temsirolimus plus carboplatin plus paclitaxel for patients with recurrent or metastatic (R/M) head and neck squamous cell cancer (HNSCC).

Cancer Chemother Pharmacol 2012 Jul 27;70(1):121-8. Epub 2012 May 27.

Department of Medicine, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, Box 532, New York, NY 10021, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00280-012-1894-yDOI Listing
July 2012

Target volume delineation in oropharyngeal cancer: impact of PET, MRI, and physical examination.

Int J Radiat Oncol Biol Phys 2012 May 27;83(1):220-7. Epub 2011 Oct 27.

Department of Radiation Oncology, Memorial Sloan-Kettering Cancer Center, New York, NY, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijrobp.2011.05.060DOI Listing
May 2012

A phase I study of daily everolimus plus low-dose weekly cisplatin for patients with advanced solid tumors.

Cancer Chemother Pharmacol 2012 Mar 13;69(3):591-8. Epub 2011 Sep 13.

Department of Medicine, Head and Neck Medical Oncology Service, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, Box 532, New York, NY, 10021, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00280-011-1734-5DOI Listing
March 2012

Tissue microarray evidence of association between p16 and phosphorylated eIF4E in tonsillar squamous cell carcinoma.

Head Neck 2011 Sep 10;33(9):1340-5. Epub 2010 Nov 10.

Head and Neck Medical Oncology Service, Memorial Sloan-Kettering Cancer Center, New York, New York 10021, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/hed.21621DOI Listing
September 2011

Current recommendations for systemic therapy of recurrent and/or metastatic head and neck squamous cell cancer.

J Natl Compr Canc Netw 2011 Jun;9(6):681-9

Head and Neck Medical Oncology Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York 10021, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.6004/jnccn.2011.0056DOI Listing
June 2011

Phase II study of saracatinib (AZD0530) for patients with recurrent or metastatic head and neck squamous cell carcinoma (HNSCC).

Anticancer Res 2011 Jan;31(1):249-53

Head and Neck Medical Oncology Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3705960PMC
January 2011

Systemic therapy in the management of metastatic or locally recurrent adenoid cystic carcinoma of the salivary glands: a systematic review.

Lancet Oncol 2011 Aug 10;12(8):815-24. Epub 2010 Dec 10.

Ottawa Hospital Cancer Centre, Division of Medical Oncology, Department of Medicine, University of Ottawa, Ottawa, ON, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S1470-2045(10)70245-XDOI Listing
August 2011

A phase 2 study of pemetrexed plus gemcitabine every 2 weeks for patients with recurrent or metastatic head and neck squamous cell cancer.

Cancer 2011 Feb 4;117(4):795-801. Epub 2010 Oct 4.

Head and Neck Medical Oncology Service, Memorial Sloan-Kettering Cancer Center, New York, New York, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.25464DOI Listing
February 2011

Induction chemotherapy in the management of head and neck cancer.

J Surg Oncol 2010 Mar;101(4):292-8

Head and Neck Medical Oncology Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York 10065, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/jso.21438DOI Listing
March 2010

A phase-I trial of the epidermal growth factor receptor directed bispecific antibody MDX-447 without and with recombinant human granulocyte-colony stimulating factor in patients with advanced solid tumors.

Cancer Immunol Immunother 2008 Feb 30;57(2):155-63. Epub 2007 Jun 30.

Division of Solid Tumor Oncology, Head and Neck Medical Oncology Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00262-007-0357-5DOI Listing
February 2008

A Phase II study of SU5416 in patients with advanced or recurrent head and neck cancers.

Invest New Drugs 2007 Apr 16;25(2):165-72. Epub 2006 Sep 16.

Head and Neck Medical Oncology Service, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10637-006-9011-xDOI Listing
April 2007

A phase I trial of intermittent high-dose gefitinib and fixed-dose docetaxel in patients with advanced solid tumors.

Cancer Chemother Pharmacol 2007 Mar 1;59(4):467-75. Epub 2006 Aug 1.

Division of Solid Tumor Oncology, Head and Neck Oncology Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center and Weill Medical College of Cornell University, New York, NY 10021, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00280-006-0286-6DOI Listing
March 2007

A phase I clinical pharmacologic study of pralatrexate in combination with probenecid in adults with advanced solid tumors.

Cancer Chemother Pharmacol 2006 May 31;57(5):671-7. Epub 2005 Aug 31.

Thoracic Oncology Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY, 10021, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00280-005-0080-xDOI Listing
May 2006

A 14-year retrospective review of angiosarcoma: clinical characteristics, prognostic factors, and treatment outcomes with surgery and chemotherapy.

Cancer J 2005 May-Jun;11(3):241-7

Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York 10021-6007, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/00130404-200505000-00011DOI Listing
October 2005